Cancer Biomarkers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Mar-2020 | List of Tables : 18 | List of Figures : 64 | No. of Pages : 170 | Report Code : FACT4587MR |

Global Cancer Biomarker Market to Increase Two-Fold, Amid Greater Funding for Research

The World Health Organization (WHO) estimates that cancer kills 8.3 million people every year. It further projects that 7 out of 10 patients will be diagnosed with cancer in the future. Each cancer type requires different kinds of treatment. Consequently, governments across the world are funding cancer research to facilitate diagnosis and treatment. In addition, clinical trials are also funded by governments to support companies engaged in the diagnosis and treatment of the disease. On the back of these factors, the global cancer biomarkers market is anticipated to grow at a staggering CAGR of 12.2% during the forecast period (2020-2025). Availability of less-invasive and inexpensive prognosis shall further augment the demand for biomarkers in the market.

Circulating Tumor Cells (CTC) Segment to Register Impressive Growth, Prostate-Specific Antigen (PSA) Buckling Up

The Circulating Tumor Cells (CTC) Test segment is projected to enjoy the maximum market share during the forecast period. CAGR for the same is pegged at 13.0%, thus giving an uptick to demand for the cancer biomarkers within the market. This is attributed to its simplicity and early assessment of patient prognosis. CTC test segment is closely followed by the Prostate-Specific Antigen (PSA) test segment, which accounts for over one-fifth of the global cancer biomarkers market.

North America to Lead Global Sales, Asia-Pacific to Show Prolific Growth

North America remains the most prominent market, accounting for more than 40% of the global cancer biomarkers market. This is expected to gain further traction during the forecast period. An absolute $ opportunity of US$ 5.2 Bn is anticipated for the region during the forecast period. This is due to heavy budget allocation by the government for cancer research and training. However, Asia-Pacific is expected to surpass North America, owing to greater affordability of cancer treatments by patients. Projected CAGR for Asia Pacific is pegged at ~14% during the forecast period.

cancer biomarkers market 03

For critical regional insights on the cancer biomarkers market, ask an analyst here

Innovations, Product Development & AI to Provide Competitive Edge to Market Players

The global cancer biomarkers market is highly consolidated. The top 3 players hold half of the total market share. F. Hoffmann-La Roche Ltd is an important player in the cancer biomarkers market, providing wide ranging solutions for tumor biomarker tests. The WHO has designated 29 medicines developed by La Roche in the Model List of Essential Medicines, including life-saving antibiotics, anti-malarial and chemotherapy. More recently, the company’s TECENTRIQ prescription medicine received approval from the Food & Drug Administration (FDA). The medicine is intended to provide initial therapy for squamous and non-squamous non-small cell lung cancer (NSCLC). Another key player, Abbott Laboratories, concentrates on innovations and development of new technologies to provide cancer diagnosis and treatments. Moreover, it constructs country-specific portfolios consisting of local and global pharmaceutical brands. Its products offer in vitro diagnostics and assists in early detection of cancers.

cancer biomarkers market 01

To get an exhaustive overview of the cancer biomarkers market, request for a report sample here

Amongst the smaller players, Novartis AG has a significant presence in the global cancer biomarkers market. A key strategy adopted by the company is the use of Artificial Intelligence (AI) to decode cancer pathology. Collaborating with the tech start-up PathAI, the company has been able to successfully detect cancers with diminished error margins. Moreover, the company is also committed to reducing the ill-effects of cancer within the workplace. Its ‘Ensemble-Caring for Colleagues’ initiative aims to provide emotional and physical support to those affected by the disease. Additionally, it also provides support to cancer caregivers, and guides them on how to best support patients from a managerial perspective. Other important market players are: Thermo Fisher Scientific Inc., Agilent Technologies, Illumina, Inc., bioMérieux SA, Hologic, Inc., Genomic Health, Inc. and QIAGEN.

Cancer Biomarkers Market- Scope of the Report

The recent study by Fact.MR on cancer biomarkers market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of cancer biomarkers market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of bentonite. The study also provides dynamics that are responsible for influencing the future status of the cancer biomarkers market over the forecast period.

A detailed assessment of cancer biomarkers market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the cancer biomarkers market along with their product portfolio enhances the reliability of this comprehensive research study.

Cancer Biomarkers Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in cancer biomarkers market across the globe.

A comprehensive estimate of cancer biomarkers market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of cancer biomarkers market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Cancer Biomarkers Market Segmentation

Fact.MR has studied the cancer biomarkers market with detailed segmentation on the basis of test type, disease indication and key regions.

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Test Type

Disease Indication

Key Regions

PSA Tests

Blood Cancer

North America

CTC Tests

Prostate Cancer

Europe

AFP Tests

Ovarian Cancer

Asia Pacific

CA Tests

Stomach Cancer

Eastern Europe

HER2 Tests

Liver Cancer

Latin America

BRCA Tests

Others

Middle East & Africa (MEA)

ALK Tests

   

CEA Tests

 

 

EFGR Mutation Tests

   

KRAS Mutation Tests

 

 

Others

   

Cancer Biomarkers market: Analysis on Market Size Evaluation

Cancer Biomarkers market has been analyzed for each market segment, in terms of volume (Kilo tons) and value (US$ Mn).

Market estimates at global and regional levels for cancer biomarkers is available in terms of “US$ Mn” for value and in “Kilo tons” for volume. A Y-o-Y growth contrast on prominent cancer biomarkers market segments, along with market attractiveness evaluation has been incorporated in the report. Furthermore, the absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve along with identifying potential resources, considering sales and distribution perspective in the global cancer biomarkers market.

Cancer Biomarkers market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the cancer biomarkers report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (political economic, and business environment outlook), which are expected to have a momentous influence on the growth of cancer biomarkers market during the forecast period.

Country-specific valuation on demand for cancer biomarkers has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

Cancer Biomarkers market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of cancer biomarkers along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of cancer biomarkers, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the cancer biomarkers market. Prominent manufacturers with established market presence in global cancer biomarkers market are Kutch minerals, Kunimine Industries Co., Ltd., Clariant AG, Mineral Technologies Inc. and Halliburton Co.

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Cancer Biomarkers Products Market Overview

     4.1 Introduction (Product Definition)

     4.2 Industry Evolution/Development 

     4.3 Key Market Indicators

     4.4 Market Dynamics

          4.4.1 Drivers

          4.4.2 Restraints

          4.4.3 Opportunity

     4.5  Global Cancer Biomarkers Market Analysis and Forecasts, 2020 – 2025

     4.6 Cancer Biomarkers Market - Global Supply Demand Scenario

     4.7 Porter’s Five Force Analysis

     4.8 Market Outlook

     4.9 Cancer Epidemiology, by region

5. Global Cancer Biomarkers Market Analysis and Forecast by Test Type

     5.1 Key Findings

     5.2 Introduction

     5.3 Market Size (US$ Mn) Forecast, By Test Type

          5.3.1 PSA Tests

          5.3.2 CTC Tests

          5.3.3 AFP Tests

          5.3.4 CA Tests

          5.3.5 HER2 Tests

          5.3.6 BRCA Tests

          5.3.7 ALK Tests

          5.3.8 CEA Tests

          5.3.9 EGFR Mutation Tests

          5.3.10 KRAS Mutation Tests

          5.3.11 Others 

     5.4 Market Attractiveness, By Test Type

     5.5 Key Trends

6. Global Cancer Biomarkers Market Analysis and Forecast by Disease Indication

     6.1 Key Findings

     6.2 Introduction

     6.3 Market Size (US$ Mn) Forecast, By Disease Indication

          6.3.1 Breast Cancer

          6.3.2 Lung Cancer

          6.3.3 Colorectal Cancer

          6.3.4 Melanoma

          6.3.5 Blood Cancer

          6.3.6 Prostate Cancer

          6.3.7 Ovarian Cancer

          6.3.8 Stomach Cancer

          6.3.9 Liver Cancer

          6.3.10 Others

     6.4 Market Attractiveness, By Disease Indication

     6.5 Key Trends

7. Global Cancer Biomarkers Market Analysis and Forecast by Region

     7.1 Key Findings

     7.2 Introduction

          7.2.1 Market Size (US$ Mn) Forecast, By Region

          7.2.2 North America

          7.2.3 Europe

          7.2.4 Asia Pacific

          7.2.5 Latin America

          7.2.6 Middle East and Africa

8. North America Cancer Biomarkers Market Analysis and Forecast by Region

     8.1 Key Findings

     8.2 North America Cancer Biomarkers Market Forecast, by Test Type

     8.3 North America Cancer Biomarkers Market Forecast, by Disease Indication     

     8.4 North America Cancer Biomarkers Market Forecast, by Country

          8.4.1 U.S. Cancer Biomarkers Market Overview

          8.4.2 Canada Cancer Biomarkers Market Overview

     8.5 North America Market Attractiveness Analysis

     8.6 Market Trends

9. Europe Cancer Biomarkers Market Analysis and Forecast by Region

     9.1 Key Findings

     9.2 Europe Cancer Biomarkers Market Forecast, by Test Type

     9.3 Europe Cancer Biomarkers Market Forecast, by Disease Indication

     9.4 Europe Cancer Biomarkers Market Forecast, by Country

          9.4.1 U.K. Cancer Biomarkers Market Overview

          9.4.2 Germany Cancer Biomarkers Market Overview

          9.4.3 France Cancer Biomarkers Market Overview

          9.4.4 Italy Cancer Biomarkers Market Overview

          9.4.5 Spain Cancer Biomarkers Market Overview

          9.4.6 Russia Cancer Biomarkers Market Overview

          9.4.7 Rest of Europe Cancer Biomarkers Market Overview

     9.5 Europe Market Attractiveness Analysis

     9.6 Market Trends

10. Asia Pacific Cancer Biomarkers Market Analysis and Forecast by Region

     10.1 Key Findings

     10.2 Asia Pacific Cancer Biomarkers Market Forecast, by Test Type

     10.3 Asia Pacific Cancer Biomarkers Market Forecast, by Disease Indication

     10.4 Asia Pacific Cancer Biomarkers Market Forecast, by Country

          10.4.1 India Cancer Biomarkers Market Overview

          10.4.2 China Cancer Biomarkers Market Overview

          10.4.3 Japan Cancer Biomarkers Market Overview

          10.4.4 Australia & New Zealand Cancer Biomarkers Market Overview

          10.4.5 Rest of APAC Cancer Biomarkers Market Overview

     10.5 Asia Pacific Market Attractiveness Analysis

     10.6 Market Trends

11. Latin America Cancer Biomarkers Market Analysis and Forecast by Region

     11.1 Key Findings

     11.2 Latin America Cancer Biomarkers Market Forecast, by Test Type

     11.3 Latin America Cancer Biomarkers Market Forecast, by Disease Indication

     11.4 Latin America Cancer Biomarkers Market Forecast, by Country

          11.4.1 Brazil Cancer Biomarkers Market Overview

          11.4.2 Mexico Cancer Biomarkers Market Overview

          11.4.3 Rest of LATAM Cancer Biomarkers Market Overview

     11.5 Latin America Market Attractiveness Analysis

     11.6 Market Trends

12. Middle East and Africa Cancer Biomarkers Market Analysis and Forecast by Region

     12.1 Key Findings

     12.2 Middle East and Africa Cancer Biomarkers Market Forecast, by Test Type

     12.3 Middle East and Africa Cancer Biomarkers Market Forecast, by Disease Indication

     12.4 Middle East and Africa Cancer Biomarkers Market Forecast, by Country

          12.4.1 South Africa Cancer Biomarkers Market Overview

          12.4.2 GCC countries Cancer Biomarkers Market Overview

          12.4.3 Rest of MEA Cancer Biomarkers Market Overview

     12.5 Middle East and Africa Market Attractiveness Analysis

     12.6 Market Trends

13. Competitive Landscape

     13.1 Market Share Analysis, by Company

     13.2 Competition Matrix

     13.3 Company Profiles

          13.3.1 Abbott Laboratories

                   13.3.1.1 Company Details

                   13.3.1.2 Business Overview

                   13.3.1.3 Financial Overview

                   13.3.1.4 Strategic Overview

                   13.3.1.5 SWOT Analysis

          13.3.2 Merck & Co., Inc.

                   13.3.2.1 Company Details

                   13.3.2.2 Business Overview

                   13.3.2.3 Financial Overview

                   13.3.2.4 Strategic Overview

                   13.3.2.5 SWOT Analysis

          13.3.3 Thermo Fisher Scientific Inc

                   13.3.3.1 Company Details

                   13.3.3.2 Business Overview

                   13.3.3.3 Financial Overview

                   13.3.3.4 Strategic Overview

                   13.3.3.5 SWOT Analysis

          13.3.4 Illumina, Inc.

                   13.3.4.1 Company Details

                   13.3.4.2 Business Overview

                   13.3.4.3 Financial Overview

                   13.3.4.4 Strategic Overview

                   13.3.4.5 SWOT Analysis

          13.3.5 bioMérieux SA

                   13.3.5.1 Company Details

                   13.3.5.2 Business Overview

                   13.3.5.3 Financial Overview

                   13.3.5.4 Strategic Overview

                   13.3.5.5 SWOT Analysis

          13.3.6 QIAGEN

                   13.3.6.1 Company Details

                   13.3.6.2 Business Overview

                   13.3.6.3 Financial Overview

                   13.3.6.4 Strategic Overview

                   13.3.6.5 SWOT Analysis

          13.3.7 Agilent Technologies, Inc.

                   13.3.7.1 Company Details

                   13.3.7.2 Business Overview

                   13.3.7.3 Financial Overview

                   13.3.7.4 Strategic Overview

                   13.3.7.5 SWOT Analysis

          13.3.8 Hologic, Inc.

                   13.3.8.1 Company Details

                   13.3.8.2 Business Overview

                   13.3.8.3 Financial Overview

                   13.3.8.4 Strategic Overview

                   13.3.8.5 SWOT Analysis

          13.3.9 Novartis AG

                   13.3.9.1 Company Details

                   13.3.9.2 Business Overview

                   13.3.9.3 Financial Overview

                   13.3.9.4 Strategic Overview

                   13.3.9.5 SWOT Analysis

          13.3.10 F. Hoffmann-La Roche Ltd.

                   13.3.10.1 Company Details

                   13.3.10.2 Business Overview

                   13.3.10.3 Financial Overview

                   13.3.10.4 Strategic Overview

                   13.3.10.5 SWOT Analysis

          13.3.11 Genomic Health, Inc.

                   13.3.11.1 Company Details

                   13.3.11.2 Business Overview

                   13.3.11.3 Financial Overview

                   13.3.11.4 Strategic Overview

                   13.3.11.5 SWOT Analysis

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

Cancer Biomarkers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025